As filed with the Securities and Exchange
Commission on October 20, 2026.
Registration No. 333-298752
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Amendment No. 2
to the
FORM
S-1
REGISTRATION
STATEMENT
UNDER
THE SECURITIES ACT OF 1933
| T3
Defense Inc. |
| (Exact
name of registrant as specified in its charter) |
| Delaware |
|
3690 |
|
38-3912845 |
| (State or jurisdiction of |
|
(Primary
Standard Industrial |
|
(I.R.S.
Employer |
| incorporation or organization) |
|
Classification
Code Number) |
|
Identification
Number) |
575
Fifth Ave., 14th Floor
New
York, New York 10017
(646)
257-4214
(Address,
including zip code, and telephone number, including area code, of Registrant’s principal executive offices)
Menachem
Shalom
T3
Defense Inc.
Chief
Executive Officer
575
Fifth Ave., 14th Floor
New
York, New York 10017
(646)
257-4214
(Name,
address, including zip code, and telephone number, including area code, of agent for service)
Copies
to:
Robert
Cohen
McDermott
Will & Schulte LLP
333
SE 2nd Avenue, Suite 4500
Miami,
Florida 33131
(561)
287-7096
Approximate
date of commencement of proposed sale to the public:
As
soon as practicable after the effective date hereof.
If
any securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities
Act of 1933, check the following box. ☒
If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. ☐
If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer |
☐ |
Accelerated
filer |
☐ |
| Non-accelerated filer |
☒ |
Smaller reporting company
|
☒ |
| |
Emerging growth company
|
☒ |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date
as the Securities and Exchange Commission acting pursuant to said section 8(a), may determine.
EXPLANATORY NOTE
This Amendment No. 2 (this “Amendment”)
to the Registration Statement on Form S-1 of T3 Defense Inc. (File No. 333-298752) (the “Registration Statement”)
is being filed solely for the purpose of filing certain exhibits as indicated in Part II, Item 16 of this Amendment. Accordingly, this
Amendment consists only of the facing page, this explanatory note, Item 16, the signature pages to this Amendment and the filed exhibits.
Part I, consisting of the preliminary prospectus, and the balance of Part II of the Registration Statement are unchanged and have been
omitted from this Amendment.
ITEM
16. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a)
Exhibits
The
following exhibits are filed with this registration statement:
| |
|
|
Incorporated by Reference |
| Exhibit |
|
Description |
|
Schedule/
Form |
|
Exhibits |
|
Filing
Date |
| 2.1# |
|
Amended and Restated Agreement and Plan of Merger dated as of June 23, 2023, by and among Nukkleus and Brilliant. |
|
Form 8-K |
|
2.1 |
|
June 26, 2023 |
| 2.2# |
|
First Amendment to Amended and Restated Agreement and Plan of Merger dated as of November 1, 2023, by and among Nukkleus and Brilliant. |
|
Form 8-K |
|
2.2 |
|
November 2, 2023 |
| 3.1 |
|
Amended and Restated Certificate of Incorporation of Nukkleus Inc. (f/k/a Brilliant Acquisition Corp.) |
|
Form 8-K |
|
3.2 |
|
January 2, 2024 |
| 3.2 |
|
Bylaws of Nukkleus Inc. |
|
Form 8-K |
|
3.3 |
|
January 2, 2024 |
| 3.3 |
|
Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation dated October 11, 2024 |
|
Form 8-K |
|
3.1 |
|
October 18, 2024 |
| 3.4 |
|
Certificate of Correction to the Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation dated October 16, 2024 |
|
Form 8-K |
|
3.2 |
|
October 18, 2024 |
| 3.5 |
|
Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation dated October 18, 2024 |
|
Form 8-K |
|
3.3 |
|
October 18, 2024 |
| 3.6 |
|
Amended and Restated Bylaws |
|
Form 8-K |
|
3.1 |
|
November 12, 2024 |
| 3.7 |
|
Certificate of Designation, Rights, Preferences and Limitations of Series A Convertible Preferred Stock |
|
Form 8-K |
|
3.1 |
|
September 5, 2025 |
| 3.8 |
|
Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation dated February 2, 2026 |
|
Form 8-K |
|
3.8.2 |
|
February 9, 2026 |
| 3.9 |
|
Certificate of Correction to the Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation dated February 3, 2026 |
|
Form 8-K |
|
3.8.1 |
|
February 9, 2026 |
| 3.10 |
|
Certificate of Designation, Rights, Preferences and Limitations of Series B Convertible Preferred Stock |
|
Form 8-K |
|
3.1 |
|
February 25, 2026 |
| 3.11 |
|
Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation dated July 15, 2026 |
|
Form 8-K |
|
3.1 |
|
July 16, 2026 |
| 3.12† |
|
Certificate of Correction to the Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation dated August 27, 2026 |
|
|
|
|
|
|
| 4.1 |
|
Senior Unsecured Promissory Note dated June 11, 2024 issued to X Group Fund of Funds |
|
Form 8-K |
|
4.1 |
|
June 17, 2024 |
| 4.2 |
|
Common Stock Purchase Warrant issued to X Group Fund of Funds |
|
Form 8-K |
|
4.2 |
|
June 17, 2024 |
| 4.3 |
|
Senior Unsecured Promissory Note dated August 1, 2024 issued to East Asia Technology Investments Limited |
|
Form 8-K |
|
4.1 |
|
August 5, 2024 |
| 4.4 |
|
Common Stock Purchase Warrant issued to East Asia Technology Investments Limited |
|
Form 8-K |
|
4.2 |
|
August 5, 2024 |
| 4.5 |
|
Form of Senior Unsecured Promissory Note dated September 10, 2024 issued to X Group Fund of Funds |
|
Form 8-K |
|
4.1 |
|
September 12, 2024 |
| 4.6 |
|
Form of Warrant – December 2024 |
|
Form 8-K |
|
4.1 |
|
December 20, 2024 |
| 4.7 |
|
Form of Pre-Funded Common Stock Purchase Warrant – December 2024 |
|
Form 8-K |
|
4.2 |
|
December 20, 2024 |
| 4.8 |
|
Description of Securities |
|
Form 10-KT |
|
4.8 |
|
May 8, 2025 |
| 4.9 |
|
Warrant issued as of August 28, 2025 |
|
Form 8-K |
|
4.1 |
|
August 29, 2025 |
| 4.10 |
|
Warrant issued as of August 28, 2025 |
|
Form 8-K |
|
4.2 |
|
August 29, 2025 |
| 4.11 |
|
Form of Warrant |
|
Form 8-K |
|
4.1 |
|
September 5, 2025 |
| 4.12 |
|
Form of Pre-Funded Common Stock Purchase Warrant |
|
Form 8-K |
|
4.2 |
|
September 5, 2025 |
| 4.13 |
|
Secured Promissory Note, dated December 30, 2025, issued by Nukkleus Inc. in favor of Arie Shafir |
|
Form 8-K |
|
4.1 |
|
December 30, 2025 |
| 4.14 |
|
Form of Warrant to Purchase Common Stock (Star 26) |
|
Form 8-K |
|
4.13 |
|
January 13, 2026 |
| 4.15 |
|
Investment Note, dated January 12, 2026, issued by Nukkleus Inc. to Star 26 Capital Inc. |
|
Form 8-K |
|
4.14 |
|
January 13, 2026 |
| 4.16 |
|
Form of Three-Month Promissory Note (Star 26) |
|
Form 8-K |
|
4.15 |
|
January 13, 2026 |
| 4.17 |
|
Form of Six-Month Promissory Note (Star 26) |
|
Form 8-K |
|
4.16 |
|
January 13, 2026 |
| 4.18 |
|
Convertible Note, dated January 15, 2026 |
|
Form 8-K |
|
4.17 |
|
January 16, 2026 |
| 4.19 |
|
Promissory Note dated July 6, 2026 issued by T3 Defense Ltd. to X S.A. Security and Defense Ltd. |
|
Form 8-K |
|
4.19 |
|
July 9, 2026 |
| 5.1 |
|
Opinion of McDermott Will & Schulte LLP |
|
|
|
|
|
|
| 10.1* |
|
Nukkleus 2023 Equity Plan. |
|
Form 8-K |
|
10.1 |
|
January 2, 2024 |
| 10.2 |
|
Form of Registration Rights Agreement by and among Nukkleus, Brilliant and certain stockholders. |
|
Form 8-K |
|
10.3 |
|
June 26, 2023 |
| 10.3 |
|
Form of Lock-Up Agreement by and among Nukkleus, Brilliant and certain stockholders. |
|
Form 8-K |
|
10.2 |
|
June 26, 2023 |
| 10.4 |
|
General Service Agreement between Nukkleus Limited and FML Malta Limited dated May 24, 2016 |
|
Form 10-K |
|
10.4 |
|
July 12, 2024 |
| 10.5 |
|
General Service Agreement between Nukkleus Limited and FXDirectDealer LLC dated May 24, 2016 |
|
Form 10-K |
|
10.5 |
|
July 12, 2024 |
| 10.6 |
|
Amendment No. 1 dated June 3, 2016 to the General Service Agreement between Nukkleus Limited and FXDD Trading Limited |
|
Form 10-K |
|
10.6 |
|
July 12, 2024 |
| 10.7 |
|
Amendment dated October 17, 2017 of that certain General Service Agreement between Nukkleus Limited and FML Malta Limited |
|
Form 10-K |
|
10.7 |
|
July 12, 2024 |
| 10.8 |
|
Letter Agreement entered between FML Malta Ltd., FXDD Malta Limited and Nukkleus Limited |
|
Form 10-K |
|
10.8 |
|
July 12, 2024 |
| 10.9 |
|
Settlement Agreement and Stipulation dated May 28, 2024 by and between Nukkleus Inc. and Silverback Capital Corporation |
|
Form 8-K |
|
10.1 |
|
June 4, 2024 |
| 10.10 |
|
Restructuring Agreement dated June 11, 2024 between Nukkleus Inc. and X Group Fund of Funds |
|
Form 8-K |
|
10.1 |
|
June 17, 2024 |
| 10.11 |
|
Voting Agreement dated June 11, 2024 between Nukkleus Inc. and X Group Fund of Funds |
|
Form 8-K |
|
10.2 |
|
June 17, 2024 |
| 10.12 |
|
Release Agreement between Nukkleus Inc., Triton Capital Markets Ltd. and FXDirectDealer LLC dated September 30, 2024 |
|
Form 8-K |
|
10.1 |
|
October 4, 2024 |
| 10.13 |
|
Form of Exit and Settlement Agreement dated November 8, 2024 |
|
Form 8-K |
|
10.1 |
|
November 12, 2024 |
| 10.14 |
|
Securities Purchase Agreement dated November 8, 2024 |
|
Form 8-K |
|
10.2 |
|
November 12, 2024 |
| 10.15 |
|
Conversion Agreement entered with X Group Fund of Funds dated November 8, 2024 |
|
Form 8-K |
|
10.3 |
|
November 12, 2024 |
| 10.16 |
|
Settlement Agreement and Release among Nukkleus Inc., Jamal Khurshid and Match Financial Limited dated November 8, 2024 |
|
Form 8-K |
|
10.4 |
|
November 12, 2024 |
| 10.17 |
|
Letter Agreement between Nukkleus Inc. and X Group Fund of Funds dated November 14, 2024 |
|
Form 8-K |
|
10.1 |
|
November 15, 2024 |
| 10.18 |
|
Securities Purchase Agreement dated November 19, 2024 |
|
Form 8-K |
|
10.1 |
|
November 22, 2024 |
| 10.19 |
|
Standby Equity Distribution Agreement dated December 3, 2024 between Nukkleus Inc. and YA II PN, Ltd. |
|
Form 8-K |
|
10.1 |
|
December 6, 2024 |
| 10.20 |
|
Form of Convertible Promissory Notes issued to YA II PN, Ltd. |
|
Form 8-K |
|
10.2 |
|
December 6, 2024 |
| 10.21 |
|
Registration Rights Agreement dated December 3, 2024 between Nukkleus Inc. and YA II PN, Ltd. |
|
Form 8-K |
|
10.3 |
|
December 6, 2024 |
| 10.22# |
|
Securities Purchase Agreement and Call between Nukkleus Inc. Star 26 Capital Inc., the shareholders of Star 26 Capital Inc. and the representative of such shareholders, dated December 15, 2024 |
|
Form 8-K |
|
10.1 |
|
December 17, 2024 |
| 10.23# |
|
Form of Securities Purchase Agreement dated December 18, 2024 between Nukkleus Inc. and the purchasers identified therein |
|
Form 8-K |
|
10.1 |
|
December 20, 2024 |
| 10.24 |
|
Form of Registration Rights Agreement – December 2024 |
|
Form 8-K |
|
10.2 |
|
December 20, 2024 |
| 10.25 |
|
Placement Agent Agency Agreement dated December 18, 2024 between Nukkleus Inc. and Dawson James Securities Inc. |
|
Form 8-K |
|
10.3 |
|
December 20, 2024 |
| 10.26 |
|
Termination Agreement entered between Nukkleus Inc. and YA II PN Ltd dated December 19, 2024 |
|
Form 8-K |
|
10.4 |
|
December 20, 2024 |
| 10.27 |
|
Amendment No. 1 to the Securities Purchase Agreement and Call between Nukkleus Inc. Star 26 Capital Inc., the shareholders of Star 26 Capital Inc. and the representative of such shareholders, dated February 11, 2025 |
|
Form 8-K |
|
10.2 |
|
February 14, 2025 |
| 10.28* |
|
Nukkleus Inc. 2024 Equity Incentive Plan |
|
Form 10-KT |
|
10.27 |
|
May 8, 2025 |
| 10.29 |
|
Amendment No. 2 to the Securities Purchase Agreement and Call between Nukkleus Inc. Star 26 Capital Inc., the shareholders of Star 26 Capital Inc. and the representative of such shareholders, dated May 13, 2025 |
|
Form 8-K |
|
10.1 |
|
May 14, 2025 |
| 10.30 |
|
Promissory Note issued by Star 26 Capital Inc. dated May 13, 2025 |
|
Form 8-K |
|
10.2 |
|
May 14, 2025 |
| 10.31 |
|
Amendment No. 3 to the Securities Purchase Agreement and Call between Nukkleus Inc. Star 26 Capital Inc., the shareholders of Star 26 Capital Inc. and the representative of such shareholders, dated June 15, 2025 |
|
Form S-1/A |
|
10.31 |
|
June
18, 2025 |
| 10.32 |
|
Amendment No. 4 to the Securities Purchase Agreement and Call between Nukkleus Inc. Star 26 Capital Inc., the shareholders of Star 26 Capital Inc. and the representative of such shareholders, dated July 25, 2025 |
|
Form 8-K |
|
10.1 |
|
July 25, 2025 |
| 10.33 |
|
Mutual Release Agreement dated June 19, 2025 between Nukkleus Inc., East Asia Technology Investments Ltd. and PALM Global Technologies Limited |
|
Form S-1/A |
|
10.33 |
|
July 29, 2025 |
| 10.34 |
|
Warrant Agreement dated July 30, 2025 issued by Synthetic Darwin LLC to Nukkleus Inc. |
|
Form 8-K |
|
10.1 |
|
July 31, 2025 |
| 10.35 |
|
Exclusive Distribution Agreement dated August 20, 2025, between Nukkleus Inc. and Blade Ranger Ltd. |
|
Form 8-K |
|
10.1 |
|
August 25, 2025 |
| 10.36 |
|
Joint Venture Agreement dated August 28, 2025, between Nukkleus Inc. and Mandragola Aviation Ltd. |
|
Form 8-K |
|
10.1 |
|
August 29, 2025 |
| 10.37 |
|
Stock Purchase Agreement dated September 1, 2025, by and among Nukkleus Inc., Nukk Picolo Ltd., Tiltan Software Engineering Ltd., and Arie Shafir. |
|
Form 8-K |
|
10.1 |
|
September 2, 2025 |
| 10.38# |
|
Form of Securities Purchase Agreement dated September 4, 2025, between Nukkleus Inc. and the purchasers identified therein |
|
Form 8-K |
|
10.1 |
|
September 5, 2025 |
| 10.39 |
|
Form of Registration Rights Agreement, dated September 4, 2025, between Nukkleus Inc. and the signatories identified therein |
|
Form 8-K |
|
10.2 |
|
September 5, 2025 |
| 10.40 |
|
Placement Agent Agency Agreement dated September 4, 2025 between Nukkleus Inc. and Dawson James Securities Inc. |
|
Form 8-K |
|
10.3 |
|
September 5, 2025 |
| 10.41 |
|
Amended and Restated Securities Purchase Agreement and Call Option dated as of September 15, 2025 by and among Nukkleus Inc. Star 26 Capital Inc., the shareholders of Star 26 Capital Inc. and Menachem Shalom, the representative of such shareholders |
|
Form 8-K |
|
10.1 |
|
September 16, 2025 |
| 10.42 |
|
Common Stock Purchase Agreement dated as of September 19, 2025 between Nukkleus Inc. and Esousa Group Holdings, LLC |
|
Form 8-K |
|
10.1 |
|
September 19, 2025 |
| 10.43 |
|
Registration Rights Agreement dated as of September 19, 2025 between Nukkleus Inc. and Esousa Group Holdings, LLC |
|
Form 8-K |
|
10.2 |
|
September 19, 2025 |
| 10.44 |
|
Amendment to Stock Purchase Agreement, dated December 30, 2025, by and among Nukkleus Inc., Nukk Picolo Ltd., Tiltan Software Engineering Ltd., and Arie Shafir |
|
Form 8-K |
|
10.1 |
|
December 30, 2025 |
| 10.45 |
|
Pledge Agreement, dated December 30, 2025, by and between Nukk Picolo Ltd. and Arie Shafir |
|
Form 8-K |
|
10.2 |
|
December 30, 2025 |
| 10.46 |
|
Escrow Agreement, dated December 30, 2025, by and among Nukkleus Inc., Arie Shafir and Adv. Lior Hinkus, as escrow agent |
|
Form 8-K |
|
10.3 |
|
December 30, 2025 |
| 10.47 |
|
Assignment from Star 26 Capital, Inc. to each of the shareholders, dated January 12, 2026 |
|
Form 8-K |
|
10.44 |
|
January 13, 2026 |
| 10.48 |
|
Stock Purchase Agreement dated January 15, 2026 between Nukkleus Inc. and Elad Defense LLC |
|
Form
8-K |
|
10.45 |
|
January
16, 2026 |
| 10.49 |
|
Translation of the Agreement dated June 8, 2025, by and among Star Twenty Six Ltd., I.T.S. Industrial Techno-logic solutions Ltd., and Gera Eron |
|
Form
8-K |
|
10.50 |
|
February
17, 2026 |
| 10.50 |
|
Cancellation Agreement dated March 31, 2026 by and between T3 Defense Inc. and Star 26 Capital, Inc. |
|
Form
8-K |
|
10.50 |
|
April
3, 2026 |
| 10.51* |
|
Nukkleus Inc. 2025 Equity Incentive Plan |
|
Form
S-8 |
|
10.1 |
|
November
25, 2025 |
| 10.52 |
|
Stock Purchase Agreement dated as of July 6, 2026, among T3 Defense Ltd., Project 35 Ltd. and X S.A. Security and Defense Ltd. |
|
Form
8-K |
|
10.51 |
|
July
9, 2026 |
| 10.53 |
|
Securities Purchase Agreement dated as of February 24, 2026 between T3 Defense Inc. and the purchaser identified on the signature page thereto |
|
Form
8-K |
|
10.1 |
|
February
25, 2026 |
| 10.54 |
|
Registration Rights Agreement dated as of February 24, 2026 between T3 Defense Inc. and the purchaser signatory thereto |
|
Form
8-K |
|
10.2 |
|
February
25, 2026 |
| 10.55† |
|
Call Option Agreement dated January 13, 2026 between Menachem Shalom and Esousa Group Holdings LLC |
|
|
|
|
|
|
| 10.56 |
|
Cancellation Agreement dated August 28, 2026 among T3 Defense Inc., Project 35 Ltd. and X S.A. Security and Defense Ltd. |
|
Form
8-K |
|
10.52 |
|
August 31, 2026 |
| 10.57 |
|
Term Note, dated as of September 9, 2026 |
|
Form 8-K |
|
10.54 |
|
September 11, 2026 |
| 14.1 |
|
Code of Ethics |
|
Form
10-KT |
|
14.1 |
|
May
8, 2025 |
| 19.1 |
|
Insider Trading Policy |
|
Form
10-K/A |
|
19.1 |
|
April
14, 2025 |
| 21.1† |
|
List of Subsidiaries |
|
|
|
|
|
|
| 23.1† |
|
Consent of Green Growth CPA |
|
|
|
|
|
|
| 23.2 |
|
Consent of McDermott Will & Schulte LLP (included in Exhibit 5.1) |
|
|
|
|
|
|
| 23.3† |
|
Consent of KPMG Somekh Chaikin |
|
|
|
|
|
|
| 97.1 |
|
Policy for the Recovery of Erroneously Awarded Compensation adopted April 8, 2025 |
|
Form
10-K/A |
|
97.1 |
|
April
14, 2025 |
| 99.1 |
|
Policy on Granting Equity Awards |
|
Form
10-KT |
|
99.1 |
|
May
8, 2025 |
| 107† |
|
Filing Fee Table |
|
|
|
|
|
|
| * |
Indicates management contract or compensatory plan or arrangement. |
| |
|
| # |
Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601. The Registrant agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request. |
(b)
Financial Statement Schedules
See
the Index to Financial Statements included on page F-1 for a list of the financial statements included in this prospectus.
ITEM
17. UNDERTAKINGS
The
undersigned registrant hereby undertakes:
(a)
(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
(i)
To include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii)
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and
price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration
Fee” table in the effective registration statement; and
(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or
any material change to such information in the registration statement;
Provided,
however, that:
(B)
Paragraphs (a)(1)(i), (ii) and (iii) above do not apply if the information required to be included in a post-effective amendment by those
paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), that are incorporated by reference in this registration statement.
(2)
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof.
(3)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering.
(4)
That, for the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to
Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other
than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the
date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is
part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement
or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first
use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such date of first use.
(b)
The registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant’s
annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit
plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration
statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.
(c)
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling
persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of
the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred
or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed
by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements
of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in Tel Aviv, Israel on October 20, 2026.
| |
T3 DEFENSE INC. |
| |
|
|
| |
By: |
/s/ Menachem Shalom |
| |
|
Menachem Shalom |
| |
|
Chief Executive Officer
(Principal Executive Officer) |
Pursuant
to the requirements of the Securities Act of 1933, as amended, this Registration Statement on Form S-1 has been signed by the following
persons in the capacities and on the dates indicated below.
| Signature |
|
Title |
|
Date |
| |
|
|
|
|
| /s/ Menachem Shalom |
|
Chief Executive Officer and Director |
|
October 20, 2026 |
| Menachem Shalom |
|
(Principal Executive Officer) |
|
|
| |
|
|
|
|
| /s/ Shlomo Zakai |
|
Chief Financial Officer |
|
October 20, 2026 |
| Shlomo Zakai |
|
(Principal Financial and Accounting Officer) |
|
|
| |
|
|
|
|
| /s/ Shiran Fridman |
|
Director |
|
October 20, 2026 |
| Shiran Fridman |
|
|
|
|
| |
|
|
|
|
| /s/ Tomer Nagar |
|
Director |
|
October 20, 2026 |
| Tomer Nagar |
|
|
|
|
| |
|
|
|
|
| /s/ Asaf Nachum |
|
Director |
|
October 20, 2026 |
| Asaf Nachum |
|
|
|
|